Trends in adverse reactions to trimethoprim-sulfamethoxazole

Pediatrics

Volumn 131, Issue 1, 2013, Pages

  Goldman, Jennifer L ^a,d   Jackson, Mary Anne ^a   Herigon, Joshua C ^a   Hersh, Adam L ^b   Shapiro, Daniel J ^c   Leeder, J Steven ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Adverse drug reaction; Pediatrics; Physician practice patterns; Skin and soft tissue infections; Trimethoprim sulfamethoxazole

Indexed keywords

ALANINE AMINOTRANSFERASE; COTRIMOXAZOLE; HEMOGLOBIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMBULATORY CARE; ARTICLE; CHILD; CHILD HEALTH CARE; DIARRHEA; DRUG ERUPTION; DRUG EXPOSURE; DRUG FEVER; DRUG SAFETY; DRUG USE; EPIDEMIC; HEALTH CARE SURVEY; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD REVIEW; MENTAL HEALTH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MUCOSAL DISEASE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PEDIATRIC HOSPITAL; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN INFECTION; SOFT TISSUE INFECTION; THROMBOCYTE COUNT; TREND STUDY; URINARY TRACT INFECTION; VOMITING;

EID: 84872832496     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-1619     Document Type: Article

References (23)

1. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: A systematic review and metaanalysis of prospective studies. Br J Clin Pharmacol. 2001;52(1):77-83
2. Bourgeois FT, Mandl KD, Valim C, Shannon MW. Pediatric adverse drug events in the outpatient setting: An 11-year national analysis. Pediatrics. 2009;124(4). Available at: Www.pediatrics.org/cgi/content/full/124/2/e744
3. Mitchell AA, Lacouture PG, Sheehan JE, Kauffman RE, Shapiro S. Adverse drug reactions in children leading to hospital admission. Pediatrics. 1988;82(1):24-29
4. Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibioticassociated adverse events. Clin Infect Dis. 2008;47(6):735-743
5. Frisch JM. Clinical experience with adverse reactions to trimethoprim-sulfamethoxazole. J Infect Dis. 1973;128(suppl):607-612
6. Levi N, Bastuji-Garin S, Mockenhaupt M, et al. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: A pooled analysis. Pediatrics. 2009;123(2). Available at: Www.pediatrics.org/ cgi/content/full/123/2/e297
7. Rieder MJ, King SM, Read S. Adverse reactions to trimethoprim- sulfamethoxazole among children with human immunodeficiency virus infection. Pediatr Infect Dis J. 1997;16(11):1028-1031
8. Karpman E, Kurzrock EA. Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children. J Urol. 2004;172 (2):448-453
9. Gutman LT. The use of trimethoprimsulfamethoxazole in children: A review of adverse reactions and indications. Pediatr Infect Dis. 1984;3(4):349-357
10. Uhari M, Nuutinen M, Turtinen J. Adverse reactions in children during long-term antimicrobial therapy. Pediatr Infect Dis J. 1996;15(5):404-408
11. Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillinresistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis. 2009;49(1):65-71
12. Frei CR, Makos BR, Daniels KR, Oramasionwu CU. Emergence of communityacquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children. J Pediatr Surg. 2010;45(10):1967-1974
13. Purcell K, Fergie J. Epidemic of communityacquired methicillin-resistant Staphylococcus aureus infections: A 14-year study at Driscoll Children's Hospital. Arch Pediatr Adolesc Med. 2005;159(10):980-985
14. Liu C, Bayer A, Cosgrove SE, et al Infectious Diseases Society of America. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18-e55
15. Fontanarosa PB, Rennie D, DeAngelis CD. Postmarketing surveillance-lack of vigilance, lack of trust. JAMA. 2004;292(21): 2647-2650
16. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005;40(12):1785-1791
17. Pirmohamed M, Friedmann PS, Molokhia M, et al. Phenotype standardization for immunemediated drug-induced skin injury. Clin Pharmacol Ther. 2011;89(6):896-901
18. Aithal GP, Watkins PB, Andrade RJ, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89(6):806-815
19. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277(4):301-306
20. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr Infect Dis J. 2004;23(2):123-127
21. Duong M, Markwell S, Peter J, Barenkamp S. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med. 2010;55(5):401-407
22. Stevens DL, Bisno AL, Chambers HF, et al Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections [published correction appears in Clin Infect Dis. 2006;42(8):1219]. Clin Infect Dis. 2005;41(10):1373-1406
23. Hersh AL, Shapiro DJ, Pavia AT, Shah SS. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics. 2011; 128(6):1053-1061